Wanxue He
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Wanxue He has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Jianqiao Xu
College of Pulmonary and Critical Care Medicine, 8th Medical Center of Chinese PLA General Hospital (PLA Medical School), Beijing, China
1 shared publication - Kaifei Wang
Department of Respiratory and Critical Care Medicine, Peking University Shougang Hospital, China
1 shared publication - Kun Xiao
School of Medicine, Nankai University, Tianjin, China
1 shared publication - Lixin Xie
Senior Department of Pulmonary and Critical Care Medicine, Chinese PLA General Hospital
1 shared publication - Lixin Xie
Department of Pulmonary & Critical Care Medicine, Chinese PLA General Hospital, 28th Fuxing Road, Beijing, 100853, People's Republic of China.
1 shared publication - Nan Xiao
State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China
1 shared publication
Latest Publications
- Open Access
- 11 October 2024
- Published by Elsevier in Microbial Pathogenesis
- Vol. 197, 107009
Repetitive Acinetobacter baumannii pneumonia induces infection tolerance in mice
- 11 October 2024
- Published by Elsevier in Microbial Pathogenesis
- Vol. 197, 107009
Open AccessRepetitive Acinetobacter baumannii pneumonia induces infection tolerance in mice
- 25 July 2018
- Published by Springer Nature in Inflammation
- Vol. 41 (5) , 1582-1589
Immunodeficiency in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Chronic obstructive pulmonary disease (COPD), characterized by progressive airway inflammation and irreversible airflow limitation, leads to serious decline in life quality. The acute exacerbation of COPD (AECOPD) results in high healthcare costs as well as a significant mortality rate. The most common cause of acute exacerbation is infection. Immune deficiency, which induces dysfunction of anti-infection, plays an important role in the pathogenesis of acute exacerbation. As described in this review, the immune dysfunction in patients with AECOPD can be a major focus of efforts to therapeutic strategy.
- 25 July 2018
- Published by Springer Nature in Inflammation
- Vol. 41 (5) , 1582-1589
Immunodeficiency in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Chronic obstructive pulmonary disease (COPD), characterized by progressive airway inflammation and irreversible airflow limitation, leads to serious decline in life quality. The acute exacerbation of COPD (AECOPD) results in high healthcare costs as well as a significant mortality rate. The most common cause of acute exacerbation is infection. Immune deficiency, which induces dysfunction of anti-infection, plays an important role in the pathogenesis of acute exacerbation. As described in this review, the immune dysfunction in patients with AECOPD can be a major focus of efforts to therapeutic strategy.